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ABSTRACT
Studies evaluating the association between pulse wave velocity (PWV), a gold standard measurement of aortic stiffness 
and established markers of cardiovascular disease (CVD), with other established vascular markers or inflammation 
among young adult is still scarce. A systematic review of the literature was conducted to identify relevant studies on the 
association between PWV with other vascular markers or inflammation. Relevant articles from Ovid Medline, Science 
Direct and Scopus databases were explored between 2009 and March 2018. Original articles published in English 
measuring any correlation between carotid-femoral PWV (PWVcf) with either augmentation index (AIx), carotid intima 
media thickness (CIMT) or C-reactive protein (CRP) on young adult with age range between 18 and 45 years old were 
included. The literature search identified 21 potential articles to be reviewed, which meet all the inclusion criteria. 
Four articles investigated the correlation between PWVcf with CRP, however only two studies gave significant but weak 
correlations. As for CIMT, a single relevant article was found and the correlation was not significant. In conclusion, lack 
of association between PWV and other vascular markers and inflammation may suggest that these vascular markers have 
their own property in assessing vascular status. Thus, these markers should be measured independently for comprehensive 
assessment of future CVD risk. 
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ABSTRAK
Halaju gelombang nadi (PWV) merupakan satu pengukuran piawai kekakuan aorta dan merupakan penanda terkenal 
penyakit kardiovaskular (CVD). Namun, kajian yang menilai hubungan antara PWV dengan penanda vaskular terkenal 
yang lain dan inflamasi masih terhad. Sorotan kajian yang sistematik telah dijalankan bagi mengenal pasti kajian yang 
mengukur hubungan antara PWV dengan penanda vaskular lain atau inflamasi. Pangkalan data Ovid Medline, Science 
Direct dan Scopus digunakan untuk mencari makalah berkaitan yang diterbitkan dari tahun 2009 sehingga Mac 2018. 
Hanya makalah asal yang diterbitkan dalam bahasa Inggeris dan mengukur sebarang korelasi antara PWV karotid-
femoral (PWVcf) dengan indeks augmentasi (AIx), ketebalan intima media arteri karotid (CIMT) atau protein C-reaktif 
(CRP) ke atas populasi muda dengan julat umur 18 hingga 45 tahun diterima. Terdapat 21 makalah yang memenuhi semua 
kriteria kemasukan dan layak untuk dikaji dan dinilai. Empat makalah mengkaji hubungan antara PWVcf dengan CRP, 
namun hanya dua kajian menunjukkan hubungan yang signifikan namun lemah. Untuk CIMT, satu kajian yang berkaitan 
telah didapati dan hubungannya dengan PWV adalah tidak signifikan. Kesimpulannya, kekurangan hubungan antara PWV 
dengan penanda vaskular lain dan inflamasi mungkin menunjukkan setiap penanda vaskular mempunyai sifat tersendiri 
dalam menilai status vaskular. Sehubungan itu, penanda vaskular tersebut perlu diukur secara berasingan bagi menilai 
risiko CVD akan datang secara menyeluruh. 
Kata kunci: Halaju gelombang nadi karotid-femoral; inflamasi; kekakuan vaskular; orang muda
INTRODUCTION
Cardiovascular diseases (CVD) remain the most important 
cause of mortality worldwide. As reported by World Health 
Organization (2017), more than three-quarters of heart 
disease and stroke-related death occur in low- and middle-
income countries. As CVD have a prolonged asymptomatic 
period, it provides an opportunity for early preventive 
interventions. Assessment of future cardiovascular disease 
(CVD) risk using vascular markers has been extensively 
studied. Measurement of arterial stiffness (AS) becomes 
one of the promising method in assessing cardiovascular 
risk as it is one of the earliest detectable manifestation of 
adverse structural and functional changes within the vessel 
wall (Stoner et al. 2012). Generally, AS will lead to thicker 
vessel and lesser inner diameter, which eventually reduce 
vessel compliance (Zahedi et al. 2007).
 Quantification of AS using pulse wave velocity (PWV) 
has been considered the most validated non-invasive 
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method. PWV is calculated by measuring the speed of 
pulse transit of the forward pressure waveforms from 
aorta to the vascular tree (Qawqzeh et al. 2011). The 
pulse transit from carotid to femoral, known as carotid-
femoral PWV (PWVcf) becomes a gold standard for AS for 
its simplicity, reproducibility and give strong prediction 
of the adverse outcome (Stoner et al. 2012). PWVcf reflects 
the estimation of arterial PWV through the entire aorta 
(Laurent et al. 2006). A compliant and distensible blood 
vessel will conduct slower pulse wave compared to a 
stiffer blood vessel (Oliver & Webb 2003). Thus, PWV 
inversely correlates to vascular compliance whereby any 
increment in PWV is linked to cardiovascular risk factors 
and eventually predicts future cardiovascular events and 
all-cause mortality (Vlachopoulos et al. 2010).
 Other than PWV, there are other cardiovascular 
disease markers that have been used to predict primary 
cardiovascular event, namely: Augmentation Index (AIx); 
carotid intima-media thickness (CIMT) and; C-Reactive 
Protein (CRP) (Greenland et al. 2010; Polak et al. 2011; 
Roberfroid et al. 2013). AIx is another measurement of 
AS, which represents a wave reflection that arrives back 
to the aorta after the forward wave, hits the peripheral 
artery (Laurent et al. 2007). CIMT measures the thickness 
of two arterial walls, namely tunica media and tunica 
intima. It has been used as a marker of early arterial wall 
alteration in detecting early to late stages of subclinical 
atherosclerosis (Pignoli et al. 1986). CRP is an established 
inflammatory marker for CVD which plays an important 
role in atherosclerotic process (Nilsson 2005).
 A great number of studies have been conducted 
in order to assess AS by measuring PWV and other 
cardiovascular risk markers. However, evaluation on the 
association between PWVcf and other cardiovascular risk 
markers is still scarce, especially in young population. 
As CVD have a prolonged asymptomatic period and AS is 
a good predictor for future cardiovascular event, study 
involving young population is strongly needed. Therefore, 
the aim of this review was to study the existing association 
between pulse wave velocity with other vascular markers 
and inflammation among young adults. 
MATERIALS AND METHODS
LITERATURE REVIEW
A systematic review of the literature was performed to 
identify the relevant previous studies focusing on the 
association between pulse wave velocity with other 
vascular markers and inflammation in young adults. A 
comprehensive search in Ovid Medline, Science Direct 
and Scopus databases (published between 2009 and March 
2018) was conducted. The search strategy involved a 
combination of three (3) keywords: ‘pulse wave velocity’ 
OR ‘aortic stiffness’; ‘carotid intima media thickness’ OR 
‘augmentation index’ OR (‘inflammation’ OR ‘c-reactive 
protein’); AND ‘young adult*.
SELECTION OF RESEARCH ARTICLES
Articles selected were limited to English language 
publications. Review articles, supplementary issues, 
proceedings, poster presentations, books, bibliography, 
consensus/statement/guidelines, case reports, subject/
keyword index, letters to editor and commentary were 
excluded from the review. For this review, only studies 
reported the association of pulse wave velocity with: 
other vascular markers or inflammation in young adults 
were included.
INCLUSION AND EXCLUSION CRITERIA
For the purpose of this review, only studies that reported 
direct association between PWV with at least one of the 
selected vascular marker, or C-reactive protein in young 
adults were included. The measurement of pulse wave 
velocity includes carotid-femoral PWV (PWVcf). Studies 
included must measure at least one of these cardiovascular 
risk markers: augmentation index (AIx); carotid intima-
media thickness (CIMT) or C-reactive protein (CRP). In term 
of young adults, only studies involving subjects with age 
range of 18 - 45 years old were included in this review.
DATA EXTRACTION AND MANAGEMENT
Prior to review, selected articles were screened in three 
(3) phases. In the first phase, any articles that did not 
meet up the inclusion based solely on title and keywords 
criteria were excluded. Second phase involved screening 
the abstract of remaining articles and further exclusion if 
the articles did not fulfill the inclusion criteria. The final 
phase is the critical part where thorough reading by two (2) 
independent reviewers was done to exclude any articles that 
did not meet the inclusion criteria. Final selection of articles 
is based on mutual agreement by all reviewers on the 
inclusion criteria before any data extraction was conducted. 
Any difference of opinion between reviewers was resolved 
through discussion. A data extraction form was designed to 
obtain a standardized data collection comprising these data: 
population and sample size; mean age; age range; male 
percentage; distance of PWV measured; and association 
of PWVcf with selected vascular markers or inflammation. 
Data extraction process was conducted independently 
using the standardized form.
SEARCH RESULTS
The literature searches in three (3) databases identified 903 
potential relevant articles. Initial independent screening 
by two reviewers excluded 488 articles that did not meet 
the inclusion criteria, based on the title and abstract. 327 
articles were further excluded because they were not related 
to PWVcf or aPWV, or no measurement of association with 
other vascular markers or inflammation of interest and not 
involving young adults. From the remaining 88 articles, 26 
were further excluded due to duplication. After thorough 
reading by both reviewers, 21 from 62 articles were valid 
for further assessment and data extraction for this review. 
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Any difference of opinion between reviewers was resolved 
through discussion. Flow of article selection and exclusion 
was showed in Figure 1.
STUDY CHARACTERISTICS
The summary of the characteristics of all studies is 
shown in Table 1. All studies were published between the 
year 2009 and March 2018. 21 studies were thoroughly 
reviewed. Method of PWV measurement includes 
tonometry, oscillometry and Doppler. However, in this 
review, we only include PWV measurement using tonometry 
or oscillometry method. Among them, five studies focus 
on direct association of PWVcf with other vascular markers 
or inflammation. Only study conducted by Kerkhof et al. 
(2012) measures the association with CIMT. However, the 
correlation is not significant in apparently healthy young 
adults. The other remaining studies measure the association 
of PWVcf with CRP or hsCRP, a marker of inflammation. The 
subjects recruited in the studies vary which include healthy 
young men, normotensive overweight and obese subjects, 
inflammatory bowel disease, juvenile idiopathic arthritis 
and non-alcoholic fatty liver disease patients. Merely two 
studies showed significant correlation (Cooper et al. 2012; 
Ozturk et al. 2015a), however the correlations were weak. 
RESULTS AND DISCUSSION
PWV is used as a measurement of arterial stiffness. The 
pulse wave travels along the arteries and the velocity 
depends on the mechanical properties of the arterial walls. 
It provides insight on the elastic properties of arterial 
system. The elasticity of the vessels decreased from the 
large arteries to the peripheral muscular arteries, resulting 
in higher PWV as it travels away from the heart. Besides, 
other factors involved in pathological processes also 
influence the value of PWV (Wilmer et al. 2005). In general, 
higher PWV is associated with lower vessel distensibility 
and compliance and consequently higher AS. 
 Shear stress imposed on the vessel walls and 
local disruption of elastic properties of the vessels can 
generate AS. This condition will affect the functional 
FIGURE 1. Flowchart of the selection process
Identification of abstracts:
Ovid Medline = 423, Science Direct = 400 & SCOPUS = 80
TOTAL = 903
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properties of large arteries and marks the early stage of 
atherosclerosis. PWVcf, a gold-standard marker of AS, 
has been established as an independent and important 
predictor of future cardiovascular events in patients 
with diabetes, renal failure and hypertension (Blacher et 
al. 1999; Cruickshank et al. 2002; Laurent et al. 2001). 
Additionally, it also applies to the general population and 
apparently healthy subjects (Mattace-Raso et al. 2006; 
Willum-Hansen et al. 2006). 
 The literature search found that only one study 
reported the correlation between PWVcf and CIMT 
(Kerkhof et al. 2012). However, the correlation is not 
significant. The scarceness of this association might be 
due to our narrow focus on young population between 
18-45 years old. In older population, various study 
showed significant association between both markers. For 
instance, a study conducted on 320 subjects, mean age 
57.11 ± 15.47 years, with various degrees of abnormality 
in cardiac structure and function showed a significant 
correlation between PWVcf with CIMT and AIx (Yu et al. 
2008). In older hypertensive patients, aortic PWV (aPWV) 
significantly associated with CIMT and age, signifies 
the role of aging in AS (Geraci et al. 2016). It has been 
shown that aging triggers the gradual replacement of the 
degenerated elastic fibres with collagenous fibres. This 
leads to structural change of the vessel and increases AS 
and eventually increases PWV. Besides that, any structural 
changes that occur at an early stage may develop slowly 
and might show a non-significant association (Aminuddin 
et al. 2014).
 Different property of vessel measurement might 
contribute to the absence of significant correlation 
between PWVcf and CIMT. PWV is related to vessel 
function while CIMT signify the vessel structural 
change. AS, measured by PWV, occurs when there is 
imbalance of collagen and elastin in the arterial wall. 
This imbalance leads to overproduction of abnormal 
collagen and diminished quantities of normal elastin, 
which contribute to vascular stiffness. In addition, change 
in elastin production and molecular repair mechanisms 
further promote the loss of vascular elasticity. Formation 
of advanced glycation end products collagen (AGEs-
link collagen) also stimulates stress signaling and 
inflammatory responses. In turn, matrix metalloproteases 
(MMPs) will be activated and cause elastin and collagen 
breakdown. This will eventually lead to vascular stiffness 
(Wallace et al. 2005; Zieman et al. 2005). On the other 
hand, CIMT evaluates the thickness of tunica media and 
intima layer of arterial wall. Mainly, vessel walls are 
composed of tunica intima, media and adventitia. Damage 
on the intima surface due to hyperlipidemia attracts 
migration of smooth muscle cells (SMCs) into the intima 
layer. Excessive proliferation of SMCs and apoptosis 
suppression resulting in arterial wall fibrosis and thickens 
the luminal stenosis via synthesis of extracellular matrix 
and lipid deposition (Ross & Glomset 1973). Thickening 
of this intima-media layer of carotid artery may reflect 
early stage of atherosclerosis (Nafikudin et al. 2003).
 AIx is a measurement of wave reflection to the aortic 
waveform. It typically refers to the ratio or percentage of 
pressure variations in the vascular bed (Sohani et al. 2012). 
The value of AIx depends on PWV and reflected pressure 
wave magnitude and site. This will provide a valuation of 
large artery (systemic) stiffness (Safar & London 2000). 
In contrast, the reflected waveform timing provides aPWV 
estimation and thus aortic stiffness (Marchais et al. 1993; 
Murgo et al. 1980). Due to various factors affecting AIx 
such as peripheral vasodilation, height and heart rate 
(Laurent et al. 2007), the association between PWV and AIx 
may not be straightforward and their use in determining 
the vascular stiffness may have different outcome. For 
example, some studies showed both PWV and AIx increased 
in subjects with risk factors (Ghiadoni et al. 2008; Pietri et 
al. 2006), while some studies observed an increased in PWV 
but not AIx (Aminuddin et al. 2013; Vyssoulis et al. 2010). 
This review showed that there was limited study carried 
out to determine the association between PWV and AIx in 
the young subjects. Future studies should be conducted to 
address this issue. 
 In term of association with inflammation, we selected 
CRP or hsCRP as our marker of inflammation. CRP has been 
found as an independent predictor both in CVD patients 
(Liuzzo et al. 1994; Nuruddin et al. 2016; Ridker et al. 
1998) and healthy individuals (Hamidon et al. 2004; Ridker 
et al. 2002, 1997). From this investigation, five studies 
showed correlation between PWVcf and CRP or hsCRP, but 
only two gave significant correlations (Aulie et al. 2014; 
Cooper et al. 2012; Ozturk et al. 2015a, 2015b). CRP has 
direct pro-inflammatory effects on human endothelial cells 
and can induce endothelial dysfunction (Venugopal et al. 
2002). Study by McEniery et al. (2004) demonstrates a 
positive correlation between aPWV and CRP in healthy 
individuals with age range of 16 to 83 years old. High 
level of CRP may increase AS via several mechanisms: 
Inflammation promotes endothelial dysfunction (Jadhav 
& Kadam 2005; Kharbanda et al. 2002); inflammation 
increases MMPs level and cause elastin and collagen 
breakdown (Wallace et al. 2005; Zieman et al. 2005); and 
in relation to insulin resistance, inflammation increases 
the production of AGEs-link collagen in the arterial wall 
which is stiffer than normal collagen (Festa et al. 2000; 
Ramasamy et al. 2010). In the young, PWV is weakly related 
to CRP, which may be due to young age, where vascular 
structure is still intact and any vascular alteration may take 
longer time to change.
CONCLUSION
Lack and weak association between PWV and other 
vascular markers and inflammation may suggest that these 
vascular markers have their own property in assessing 
vascular status. Thus, these markers should be measured 
independently for comprehensive assessment of future 
CVD risk. However, this conclusion is based on limited 
number of papers and future studies should be conducted 
to address these issues.
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